Global Merkel Cell Carcinoma Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 151239
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally occurs most often on sun-exposed areas of the skin. 

Scope of the Report:

This report focuses on the Merkel Cell Carcinoma Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Merkel Cell Carcinoma Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Merck

Amgen Inc

Apcure SAS

BeiGene Ltd

Immune Design Corp

Merck & Co Inc

Merck KGaA

Millennium Pharmaceuticals Inc

NantKwest Inc

Novartis AG

OncoSec Medical Inc

Oncovir Inc

Ono Pharmaceutical Co Ltd

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chemotherapy

Immunotherapy

Combination Therapies

Others

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centres

Others

There are 15 Chapters to deeply display the global Merkel Cell Carcinoma Treatment market.

Chapter 1, to describe Merkel Cell Carcinoma Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Merkel Cell Carcinoma Treatment, with sales, revenue, and price of Merkel Cell Carcinoma Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Merkel Cell Carcinoma Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Merkel Cell Carcinoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Merkel Cell Carcinoma Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Merkel Cell Carcinoma Treatment Introduction

1.2 Market Analysis by Type

1.2.1 Chemotherapy

1.2.2 Immunotherapy

1.2.3 Combination Therapies

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Centres

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Merkel Cell Carcinoma Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen Inc

2.2.1 Business Overview

2.2.2 Merkel Cell Carcinoma Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Apcure SAS

2.3.1 Business Overview

2.3.2 Merkel Cell Carcinoma Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Apcure SAS Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 BeiGene Ltd

2.4.1 Business Overview

2.4.2 Merkel Cell Carcinoma Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BeiGene Ltd Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Immune Design Corp

2.5.1 Business Overview

2.5.2 Merkel Cell Carcinoma Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Immune Design Corp Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck & Co Inc

2.6.1 Business Overview

2.6.2 Merkel Cell Carcinoma Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck & Co Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck KGaA

2.7.1 Business Overview

2.7.2 Merkel Cell Carcinoma Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck KGaA Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Millennium Pharmaceuticals Inc

2.8.1 Business Overview

2.8.2 Merkel Cell Carcinoma Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 NantKwest Inc

2.9.1 Business Overview

2.9.2 Merkel Cell Carcinoma Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 NantKwest Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Novartis AG

2.10.1 Business Overview

2.10.2 Merkel Cell Carcinoma Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Novartis AG Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 OncoSec Medical Inc

2.11.1 Business Overview

2.11.2 Merkel Cell Carcinoma Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 OncoSec Medical Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Oncovir Inc

2.12.1 Business Overview

2.12.2 Merkel Cell Carcinoma Treatment Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Oncovir Inc Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Ono Pharmaceutical Co Ltd

2.13.1 Business Overview

2.13.2 Merkel Cell Carcinoma Treatment Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Merkel Cell Carcinoma Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Merkel Cell Carcinoma Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Merkel Cell Carcinoma Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Merkel Cell Carcinoma Treatment Manufacturer Market Share in 2017

3.3.2 Top 6 Merkel Cell Carcinoma Treatment Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Merkel Cell Carcinoma Treatment Market Analysis by Regions

4.1 Global Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Merkel Cell Carcinoma Treatment Sales and Market Share by Regions (2013-2018)

4.1.2 Global Merkel Cell Carcinoma Treatment Revenue and Market Share by Regions (2013-2018)

4.2 North America Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

4.3 Europe Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

4.5 South America Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

5 North America Merkel Cell Carcinoma Treatment by Countries

5.1 North America Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries

5.1.1 North America Merkel Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)

5.1.2 North America Merkel Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)

5.2 United States Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

5.3 Canada Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

5.4 Mexico Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

6 Europe Merkel Cell Carcinoma Treatment by Countries

6.1 Europe Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries

6.1.1 Europe Merkel Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Merkel Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)

6.2 Germany Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

6.3 UK Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

6.4 France Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

6.5 Russia Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

6.6 Italy Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

7 Asia-Pacific Merkel Cell Carcinoma Treatment by Countries

7.1 Asia-Pacific Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Merkel Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Merkel Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)

7.2 China Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

7.3 Japan Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

7.4 Korea Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

7.5 India Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

8 South America Merkel Cell Carcinoma Treatment by Countries

8.1 South America Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries

8.1.1 South America Merkel Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)

8.1.2 South America Merkel Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

8.3 Argentina Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

8.4 Colombia Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

9 Middle East and Africa Merkel Cell Carcinoma Treatment by Countries

9.1 Middle East and Africa Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Merkel Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Merkel Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

9.3 UAE Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

9.4 Egypt Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

9.5 Nigeria Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

9.6 South Africa Merkel Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)

10 Global Merkel Cell Carcinoma Treatment Market Segment by Type

10.1 Global Merkel Cell Carcinoma Treatment Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Merkel Cell Carcinoma Treatment Sales and Market Share by Type (2013-2018)

10.1.2 Global Merkel Cell Carcinoma Treatment Revenue and Market Share by Type (2013-2018)

10.2 Chemotherapy Sales Growth and Price

10.2.1 Global Chemotherapy Sales Growth (2013-2018)

10.2.2 Global Chemotherapy Price (2013-2018)

10.3 Immunotherapy Sales Growth and Price

10.3.1 Global Immunotherapy Sales Growth (2013-2018)

10.3.2 Global Immunotherapy Price (2013-2018)

10.4 Combination Therapies Sales Growth and Price

10.4.1 Global Combination Therapies Sales Growth (2013-2018)

10.4.2 Global Combination Therapies Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Merkel Cell Carcinoma Treatment Market Segment by Application

11.1 Global Merkel Cell Carcinoma Treatment Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centres Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.1 Global Merkel Cell Carcinoma Treatment Sales, Revenue and Growth Rate (2018-2023)

12.2 Merkel Cell Carcinoma Treatment Market Forecast by Regions (2018-2023)

12.2.1 North America Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.2.2 Europe Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.2.3 Asia-Pacific Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.2.4 South America Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.2.5 Middle East and Africa Merkel Cell Carcinoma Treatment Market Forecast (2018-2023)

12.3 Merkel Cell Carcinoma Treatment Market Forecast by Type (2018-2023)

12.3.1 Global Merkel Cell Carcinoma Treatment Sales Forecast by Type (2018-2023)

12.3.2 Global Merkel Cell Carcinoma Treatment Market Share Forecast by Type (2018-2023)

12.4 Merkel Cell Carcinoma Treatment Market Forecast by Application (2018-2023)

12.4.1 Global Merkel Cell Carcinoma Treatment Sales Forecast by Application (2018-2023)

12.4.2 Global Merkel Cell Carcinoma Treatment Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Merkel Cell Carcinoma Treatment Picture

Table Product Specifications of Merkel Cell Carcinoma Treatment

Figure Global Sales Market Share of Merkel Cell Carcinoma Tre

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery